DFX Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.
Borrower
C••••• U• 1• I••
Pharmaceuticalsgroup grade Aon a schedule nowsponsor unattributed
Also written as: C••••• Midco 2 S.À. R.L; C••••• Midco 3 S.Ã r.l; C••••• Midco S.A.R.L
What matters now
- 101¢ → 98¢consensus mark
Consensus mark 98¢ on cost, down from 101¢ a year ago, 101¢ last quarter.
Q2 2026 · The lenders' own valuations, the most direct read of what they expect to recover.
Derived7 of 7 lenders' own marks, weighted by principal
Mark path, consensus per quarter end
101¢ · 101¢ · 101¢ · 101¢ · 98¢Q2 2025 to Q2 2026
Where each lender marks it, 3 points apart
97¢100¢
Principal held
at least $970M
sum of BDC pieces, a lower bound
Fair value
$941M
98c on cost, debt pieces
Unfunded
$21.2M
commitments not yet drawn
BDC lenders
9
7 on the latest quarter
Facilities
6
0 equity pieces beside them
Next maturity
May 25, 2029
no dated debt inside 24 months
On the tape since
Sep 30, 2022
latest Jun 30, 2026
Events
5
dated, non-routine
Lender marks
each lender's own fair value over cost at Jun 30, 2026, folded to one row per lender
| Lender | Exposure | Current mark | QoQ change |
|---|---|---|---|
| B••••••••• P•••••• C••••• F••• | $832M | 98¢ | -3 pts |
| B••••••••• S•••••• L•••••• F••• | $63.5M | 97¢ | -3 pts |
| N•••• H•••• P•••••• I••••• F••• L•• | $49.2M | 99¢ | -2 pts |
| M••••• S•••••• D••••• L•••••• F••• | $13.2M | 99¢ | -2 pts |
| T• S••••• B•• L•• | $9.61M | 99¢ | -2 pts |
View all 7 lendersShow fewerlargest exposure first
| Lender | Exposure | Current mark | QoQ change |
|---|---|---|---|
| A•••••• S•••••••• C••••• F••• | $2.55M | 99¢ | 0 pts |
| A•••••• P•••••• C••••• F••• | $196K | 100¢ | 0 pts |
Every BDC piece · 26 positions across 7 lenderslargest principal first, with instrument and rate
| BDC | Instrument | Principal | Fair value | Rate |
|---|---|---|---|---|
| B••••••••• P•••••• C••••• F••• | revolver lien unstated N••••••••• I••••• | $436M | $422M 98c | S+500 bp |
| B••••••••• P•••••• C••••• F••• | revolver lien unstated N••••••••• I••••• | $243M | $236M 97c | S+500 bp |
| B••••••••• P•••••• C••••• F••• | revolver lien unstated N••••••••• I••••• | $68.8M | $66.7M 97c | S+500 bp |
| B••••••••• S•••••• L•••••• F••• | revolver lien unstated N••••••••• I••••• | $49.0M | $47.5M 97c | S+500 bp |
| B••••••••• P•••••• C••••• F••• | revolver lien unstated N••••••••• I••••• | $48.7M | $46.7M 97c | S+500 bp |
View all 26 positionsShow fewerlargest principal first
| BDC | Instrument | Principal | Fair value | Rate |
|---|---|---|---|---|
| N•••• H•••• P•••••• I••••• F••• L•• | term loan first lien Investment F•••• L••• D••• R•••••••• R••• & S••••• S +5.00% I••••••• R••• 8.73% M••••••• D | $40.2M | $39.5M 99c | SOFR+500 bp |
| B••••••••• P•••••• C••••• F••• | revolver lien unstated N••••••••• I••••• | $35.6M | $34.5M 97c | S+500 bp |
| B••••••••• S•••••• L•••••• F••• | revolver lien unstated N••••••••• I••••• | $11.1M | $10.8M 98c | S+500 bp |
| M••••• S•••••• D••••• L•••••• F••• | term loan first lien Investment F•••• L••• D••• R•••••••• R••• and S••••• S + 5.00% I••••••• rate 8.73% M•••••• | $10.8M | $10.6M 99c | SOFR+500 bp |
| T• S••••• B•• L•• | term loan first lien F•••• L••• D••• R•••••••• R••• and S••••• S + 5.00% I••••••• R••• 8.73% M••••••• D••• 05/2 | $7.8M | $7.7M 99c | SOFR+500 bp |
| N•••• H•••• P•••••• I••••• F••• L•• | term loan first lien Investment F•••• L••• D••• R•••••••• R••• & S••••• S + 5.00% I••••••• R••• 8.73% M••••••• | $5.9M | $5.8M 100c | SOFR+500 bp |
| N•••• H•••• P•••••• I••••• F••• L•• | term loan first lien Investment F•••• L••• D••• R•••••••• R••• & S••••• S + 5.00% I••••••• R••• 8.73% M••••••• | $3.1M | $3.1M 99c | SOFR+500 bp |
| A•••••• S•••••••• C••••• F••• | term loan first lien Asset T••• F•••• L••• T••• L••• R•••••••• R••• and S••••• S + 5.00% I••••••• R••• 8.75% M• | $2.6M | $2.5M 99c | SOFR+500 bp |
| B••••••••• S•••••• L•••••• F••• | revolver lien unstated N••••••••• I••••• | $2.1M | $2.1M 98c | S+500 bp |
| M••••• S•••••• D••••• L•••••• F••• | term loan first lien Investment F•••• L••• D••• R•••••••• R••• and S••••• S + 5.00% I••••••• rate 8.73% M•••••• | $1.6M | $1.5M 99c | SOFR+500 bp |
| T• S••••• B•• L•• | term loan first lien F•••• L••• D••• R•••••••• R••• and S••••• S + 5.00% I••••••• R••• 8.73% M••••••• D••• 05/2 | $1.1M | $1.1M 99c | SOFR+500 bp |
| B••••••••• S•••••• L•••••• F••• | revolver lien unstated N••••••••• I••••• | $925,000 | $886,000 97c | S+500 bp |
| M••••• S•••••• D••••• L•••••• F••• | term loan first lien Investment F•••• L••• D••• R•••••••• R••• and S••••• S + 5.00% I••••••• rate 8.73% M•••••• | $841,000 | $822,000 99c | SOFR+500 bp |
| T• S••••• B•• L•• | term loan first lien F•••• L••• D••• R•••••••• R••• and S••••• S + 5.00% I••••••• R••• 8.73% M••••••• D••• 05/2 | $614,000 | $600,000 99c | SOFR+500 bp |
| B••••••••• S•••••• L•••••• F••• | revolver lien unstated N••••••••• I••••• | $314,000 | $304,000 98c | S+500 bp |
| A•••••• P•••••• C••••• F••• | term loan first lien Asset T••• F•••• L••• T••• L••• R•••••••• R••• and S••••• S + 5.00% I••••••• R••• 8.75% M• | $196,000 | $194,000 100c | SOFR+500 bp |
| B••••••••• P•••••• C••••• F••• | revolver lien unstated R••••••• | Not disclosed | Not disclosed | S+500 bp |
| B••••••••• S•••••• L•••••• F••• | revolver lien unstated R••••••• | Not disclosed | Not disclosed | S+500 bp |
| M••••• S•••••• D••••• L•••••• F••• | revolver first lien F•••• L••• D••• C••••••••• T••• R••••••• C••••••••• E••••••••• D••• 05/25/2029 | Not disclosed | Not disclosed | S+500 bp |
| N•••• H•••• P•••••• I••••• F••• L•• | revolver first lien F•••• L••• D••• C••••••••• T••• R••••••• C••••••••• E••••••••• D••• 05/25/2029 | Not disclosed | Not disclosed | S+500 bp |
| T• S••••• B•• L•• | revolver first lien F•••• L••• D••• C••••••••• T••• R••••••• C••••••••• E••••••••• D••• 05/25/2029 | Not disclosed | Not disclosed | S+500 bp |
Capital structure as the BDCs see it
latest quarter end Jun 30, 2026
| Facility | Held | On cost | Pricing | Maturity | BDCs |
|---|---|---|---|---|---|
| revolver lien unstated | at least $895M | 97c | S+500 bp | May 25, 2029 | 4 |
| first lien term loan first lien | at least $74.8M | 99c | SOFR+500 bp | May 25, 2029 | 5 |
| first lien revolver first lien | unknown | n/a | S+500 bp | unstated | 3 |
| first lien delayed draw term loan first lien exited Sep 30, 2024 | unknown | n/a | S+500 bp | unstated | 1 |
| other lien unstated exited Jun 30, 2025 | unknown | n/a | unstated | 7 |
All 6 facilitiesShow fewerheld first, largest first
| Facility | Held | On cost | Pricing | Maturity | BDCs |
|---|---|---|---|---|---|
| delayed draw term loan lien unstated exited Sep 30, 2024 | unknown | n/a | S+500 bp | unstated | 4 |
Through time
the borrower's pieces summed across BDCs, every quarter end
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Jun 30, 2026 | 7 | $970M | $941M | 98c | 0 |
| Mar 31, 2026 | 7 | $978M | $978M | 101c | 0 |
| Dec 31, 2025 | 7 | $980M | $980M | 101c | 0 |
| Sep 30, 2025 | 7 | $958M | $958M | 101c | 0 |
All 16 quartersShow fewer
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Jun 30, 2025 | 7 | $940M | $939M | 101c | 0 |
| Mar 31, 2025 | 7 | $930M | $927M | 101c | 0 |
| Dec 31, 2024 | 7 | $1.9B | $1.9B | 101c | 0 |
| Sep 30, 2024 | 6 | $908M | $904M | 100c | 0 |
| Jun 30, 2024 | 6 | $889M | $885M | 101c | 0 |
| Mar 31, 2024 | 7 | $704M | $703M | 101c | 0 |
| Dec 31, 2023 | 6 | $626M | $622M | 101c | 0 |
| Sep 30, 2023 | 6 | $599M | $595M | 101c | 0 |
| Jun 30, 2023 | 7 | $584M | $573M | 100c | 0 |
| Mar 31, 2023 | 7 | $569M | $557M | 100c | 0 |
| Dec 31, 2022 | 7 | $565M | $549M | 99c | 0 |
| Sep 30, 2022 | 2 | $402M | $397M | 101c | 0 |
What changed
- Lender left a facilityJun 30, 2025
- Facility left every BDC scheduleJun 30, 2025
- New lender joined a facilityDec 31, 2024
- New lender joined a facilityDec 31, 2024
- New lender joined a facilityDec 31, 2024
Full timeline · 18 eventsShow fewer
- Lender left a facilityDec 31, 2024
- New lender joined a facilityDec 31, 2024
- Facility left every BDC scheduleSep 30, 2024
- Facility left every BDC scheduleSep 30, 2024
- Spread changed (observed)Jun 30, 2024
- New lender joined a facilityJun 30, 2024
- Marked down (one lender)Jun 30, 2024
- Marked down (one lender)Jun 30, 2024
- New lender joined a facilityJun 30, 2024
- Lender left a facilityJun 30, 2024
- New lender joined a facilityJun 30, 2024
- New lender joined a facilityDec 31, 2022
- New borrower on a BDC scheduleSep 30, 2022
Sponsor
No sponsor attribution: no portfolio page, deal announcement or Form D signer consensus names an owner for this borrower group.
Identity
- Group key
- CAERUSderivedthe codename stem after legal suffixes and deal words
- Spellings
- 2 across 9 BDCsderived
- Industry
- Pharmaceuticalsreportedas one filer wrote it